Medicare Enrolled
Dr. George Deriso, M.D.
Cardiovascular Disease · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deriso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deriso?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deriso
Dr. George Deriso is a cardiovascular disease specialist in Austell, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Deriso performed 2,980 Medicare services across 2,113 unique beneficiaries.
Between the years covered by Open Payments, Dr. Deriso received a total of $6,575 from 36 pharmaceutical and/or device companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deriso is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in GA
$6,575 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,980
Medicare services
Top 32% in GA for cardiovascular disease
2,113
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~157 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
900 | $6 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
705 | $89 | $283 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
387 | $10 | $58 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
215 | $63 | $179 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
170 | $49 | $231 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
125 | $28 | $99 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
69 | $11 | $46 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $115 | $380 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
46 | $60 | $259 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
44 | $96 | $256 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
43 | $16 | $58 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
41 | $4 | $20 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
31 | $2 | $19 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
28 | $20 | $94 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $62 | $192 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
27 | $14 | $51 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $101 | $339 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
21 | $6 | $20 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
14 | $14 | $62 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $118 | $389 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.9% high complexity
11.5% medium
81.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,575
Total received (2018-2024)
Avg $939/year across 7 years
Top 30% in GA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
370
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,575 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$798
2023
$882
2022
$1,384
2021
$476
2020
$395
2019
$1,375
2018
$1,265
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$257
Amgen Inc.
$150
Novo Nordisk Inc
$118
HEARTFLOW, INC.
$54
Merck Sharp & Dohme LLC
$39
E.R. Squibb & Sons, L.L.C.
$30
SANOFI-AVENTIS U.S. LLC
$24
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$21
AstraZeneca Pharmaceuticals LP
$20
Boston Scientific Corporation
$19
Janssen Pharmaceuticals, Inc
$19
Esperion Therapeutics, Inc.
$18
Kiniksa Pharmaceuticals International, plc
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 65.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,250
Amgen Inc.
$792
Janssen Pharmaceuticals, Inc
$532
AstraZeneca Pharmaceuticals LP
$526
HeartFlow, Inc.
$361
SANOFI-AVENTIS U.S. LLC
$327
Boston Scientific Corporation
$297
PFIZER INC.
$282
E.R. Squibb & Sons, L.L.C.
$243
Merck Sharp & Dohme LLC
$241
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$199
Gilead Sciences, Inc.
$195
Abbott Laboratories
$187
Novo Nordisk Inc
$138
Esperion Therapeutics, Inc.
$123
W. L. Gore & Associates, Inc.
$100
Amarin Pharma Inc.
$73
HEARTFLOW, INC.
$54
Edwards Lifesciences Corporation
$48
AngioDynamics, Inc.
$45
CARDIVA MEDICAL, INC.
$44
Allergan Inc.
$36
Pfizer Inc.
$31
BIOTRONIK INC.
$31
ARBOR PHARMACEUTICALS, INC.
$31
MEDICOMP INC
$29
PORTOLA PHARMACEUTICALS, INC.
$27
Medtronic Vascular, Inc.
$21
Regeneron Healthcare Solutions, Inc.
$20
West-Ward Pharmaceuticals
$18
Merck Sharp & Dohme Corporation
$18
Kiniksa Pharmaceuticals International, plc
$15
CVRx, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$14
Kestra Medical Technology Services, Inc.
$14
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · Bidil · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FFRct · GORE CARDIOFORM Septal Occluder · HeartWare HVAD · INVOKANA · JARDIANCE · LEQVIO · LOKELMA · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitigare · NEXLETOL · Ozempic · PRADAXA · PRALUENT · RESONATE · Repatha · Rybelsus · TELEPATCH CARDIAC MONITOR · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
265
Per 100K population
34.5
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deriso is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deriso experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Deriso performed 900 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deriso receive payments from pharmaceutical companies?
Yes. Dr. Deriso received a total of $6,575 from 36 companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deriso's costs compare to other cardiologists in Austell?
Dr. Deriso's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deriso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Austell
Browse cardiologists in Austell ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in GA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in GA
Which GA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology